Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML

Chen X, Zhao Y, Li Q, Fan S

OncoTargets and Therapy 2023, 16:409-419

Published Date: 13 June 2023